INTERGALACTIC THERAPEUTICS
Intergalactic Therapeutics is an ATP company, is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal C3DNA (covalently closed and circular DNA) molecules; a customized approach to focal therapeutic delivery using its lead delivery technology, the COMET® pulsed electric field system; and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine.
INTERGALACTIC THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2020-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.intergalactictx.com
Total Employee:
11+
Status:
Active
Total Funding:
75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Global Site Tag Nginx
Similar Organizations
Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Parthenon Therapeutics
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Current Employees Featured
Founder
Investors List
Apple Tree Partners
Apple Tree Partners investment in Series A - Intergalactic Therapeutics
Apple Tree Partners
Apple Tree Partners investment in Seed Round - Intergalactic Therapeutics
Official Site Inspections
http://www.intergalactictx.com Semrush global rank: 5.14 M Semrush visits lastest month: 1.58 K
Unable to get host informations!!!
More informations about "Intergalactic Therapeutics"
Intergalactic Therapeutics - Crunchbase Company Profile & Funding
Intergalactic Therapeutics is an ATP company, is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal C3DNA (covalently closed and …See details»
Home - InterGalactix
In a universe where all intergalactic travel is banned, Melvin and his inter-species crew, deliver any goods – all while avoiding space pirates, smugglers, and their uptight, uncompromising …See details»
Intergalactic Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Www.intergalactictx.com. Startups | Holding Company | 2020 | Massachusetts, United States | 10-50 | www.intergalactictx.com. Last update 05 Sep 2024. Overview. Pipeline. Deal. ... The …See details»
Intergalactic Therapeutics Announces Scientific Advisory Board …
ATP company, is revolutionizing focal gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal C3DNA (covalently closed and circular DNA) molecules; a …See details»
Intergalactic Therapeutics - Org Chart, Teams, Culture & Jobs
View Intergalactic Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Intergalactic Therapeutics - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Intergalactic Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Intergalactic Therapeutics - VentureRadar
"Intergalactic Therapeutics is a bio-innovation company developing, delivering, and democratizing novel non-viral gene therapies for patients. Intergalactic’s proprietary synthetic c3DNA …See details»
Intergalactic Therapeutics - Board of Directors - The Org
The board of directors at Intergalactic Therapeutics have a wide range of experience in many different industries. A few specific companies they have worked for include Braeburn, Apple …See details»
Intergalactic Therapeutics - Overview, News & Similar ... - ZoomInfo
May 16, 2023 Intergalactic Therapeutics Announces Positive Preclinical Results of Its Non-Viral Gene Therapy Platform in ABCA4 Retinopathies Data for IG-002 show for the first time that a …See details»
INTERGALACTIC THERAPEUTICS - Company Profile - Tracxn
Nov 4, 2024 INTERGALACTIC THERAPEUTICS - Developer of gene therapies for the treatment of multiple diseases. Raised a total funding of $75M over 1 round from 2 investors. Founded …See details»
Intergalactic Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Intergalactic Therapeutics, Inc. of Framingham, MA. Get the latest business insights from Dun & Bradstreet.See details»
Intergalactic Therapeutics - Craft
Intergalactic Therapeutics has 5 employees at their 1 location and $75 m in total funding,. See insights on Intergalactic Therapeutics including office locations, competitors, revenue, …See details»
Intergalactic Therapeutics Appoints Theresa G.H. Heah, M.D., …
Jan 6, 2023 For more information, visit www.intergalactictx.com. About ATP. Founded in 1999, ATP is a leader in life sciences venture capital, with $2.65 billion in committed capital and …See details»
ATP Unveils Non-Viral Gene Therapy Innovator ... - Markets Insider
NEW YORK and BOSTON, Oct. 7, 2021 /PRNewswire/ -- ATP, a leader in life sciences venture capital, today debuted Intergalactic Therapeutics, a non-viral gene therapy platform led by a …See details»
ATP Unveils Non-Viral Gene Therapy Innovator Intergalactic
NEW YORK and BOSTON, Oct. 7, 2021 /PRNewswire/ -- ATP, a leader in life sciences venture capital, today debuted Intergalactic Therapeutics, a non-viral gene therapy platform led by a …See details»
Intergalactic Therapeutics Announces Positive Preclinical
Mar 15, 2023 Data for IG-002 show for the first time that a single subretinal administration of a DNA payload encoding the human ABCA4 gene resulted in durable expression of human …See details»
Intergalactic Therapeutics Announces Positive Preclinical Results of ...
Mar 15, 2023 Data for IG-002 show for the first time that a single subretinal administration of a DNA payload encoding the human ABCA4 gene resulted in durable expression of human …See details»
ATP Unveils Non-Viral Gene Therapy Innovator Intergalactic …
NEW YORK and BOSTON, Oct. 7, 2021 /PRNewswire/ -- ATP, a leader in life sciences venture capital, today debuted Intergalactic Therapeutics, a non-viral gene therapy platform led by a …See details»
Intergalactic Therapeutics Announces Positive Results for Its Non …
Jun 27, 2023 Data from IG-002, Intergalactic's lead program, demonstrate persistent ABCA4 expression in non-human primate retinas over six months after a single administrationSee details»
Intergalactic Therapeutics to Present Updated Data From Its Non …
Apr 20, 2023 "We are excited to share encouraging preclinical data from our lead program, IG-002 targeting ABCA4-associated retinopathies.Data to be presented demonstrate for the first …See details»